Rhumbline Advisers Vaxxinity, Inc. Transaction History

Rhumbline Advisers

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	BUY	$0.62 - $0.86 $3,416 - $4,738	5,510 Added 14.09%	44,603 $32,000
Q3 2023 Nov 09, 2023	BUY	$1.25 - $3.0 $3,321 - $7,971	2,657 Added 7.29%	39,093 $53,000
Q2 2023 Aug 08, 2023	BUY	$1.73 - $2.79 $63,034 - $101,656	36,436 New	36,436 $91,000

469K

Ticker VAXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 112,150,000
Market Cap $1.12M
Description
Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology and coronaviruses in the United States. The company engages in developing UB-311 that targets toxic forms of aggregated amyloid-b in the brain to fight Alzheimer's disease (AD) that is in phase 2 clinical trial; UB-312 that...

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

Stay updated on Rhumbline Advisers with notifications on news.